Available EXPANDED_ACCESS NCT04432545

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Sponsor: Fundación Neumologica Colombiana

Conditions Pulmonary Fibrosis Pulmonary Hypertension Systemic Sclerosis Pulmonary

Interventions Mesenchymal Stem Cells from Wharton ́s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ́s jelly

Updated 5 times since 2020 Last updated: Apr 4, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pulmonary Fibrosis and Pulmonary Hypertension and is currently ongoing. Fundación Neumologica Colombiana leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Available
Jul 2024 — Sep 2024 [monthly]

Available
May 2024 — Jul 2024 [monthly]

Available
Jan 2021 — May 2024 [monthly]

Available
Jul 2020 — Jan 2021 [monthly]

Available

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Neumologica Colombiana
Innocell SAS
Stem Medicina Regenerativa
Universidad de la Sabana

Data source: Universidad de la Sabana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chía, Colombia